Clinical Trial Update: Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

View source ↗

Summary

A clinical trial evaluating a novel functional eye-tracking software for cancer-related cognitive impairment has been terminated. The sponsor was Innodem Neuros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Cognitive Impairment

Snippet

Sponsor: Innodem Neurosciences | Conditions: Cancer-related Cognitive Impairment | Status: TERMINATED